Cancer Clinical Trial
— DSNCARESNCT number | NCT03150381 |
Other study ID # | X120329018 |
Secondary ID | |
Status | Completed |
Phase | N/A |
First received | |
Last updated | |
Start date | May 1, 2012 |
Est. completion date | March 31, 2018 |
Verified date | May 2018 |
Source | University of Alabama at Birmingham |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
This study tests evidence-based strategies for weight loss among overweight and obesity cancer survivors and family members in rural Alabama.
Status | Completed |
Enrollment | 369 |
Est. completion date | March 31, 2018 |
Est. primary completion date | March 31, 2018 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 19 Years and older |
Eligibility |
Inclusion Criteria: - African American breast, colon, or prostate cancer survivor (Index Participant) - Family member (support person) of African American breast, colon, or prostate cancer survivor (Family Member Participant) - Live, work, or attend school in target county - BMI >= 25 kg/m2 Exclusion Criteria: - Pregnant or planning to become pregnant in the next year - Known major medical or psychological condition known to influence body weight - Uncontrolled hypertension (BP > 160 mmHg systolic or >100 mmHg diastolic) - medicated or poorly controlled diabetes (glucose > 126) Cardiovascular event in the preceding 12 months - History of gastric bypass or bariatric surgery - History of psychiatric hospitalization in past 2 years - History of substance abuse or eating disorder - Any other condition by which a medical professional has suggested diet modification, physical activity and/or weight reduction would be contraindicated |
Country | Name | City | State |
---|---|---|---|
United States | University of Alabama at Birmingham | Birmingham | Alabama |
Lead Sponsor | Collaborator |
---|---|
University of Alabama at Birmingham |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Weight | Measured weight (nearest kg) | Baseline to 6 months | |
Secondary | Waist Circumference | Measured circumference (nearest cm) | Baseline to 24 months | |
Secondary | Lipids | Measured total cholesterol, triglycerides, HDL, LDL, ratio (mg/dL) | Baseline to 24 months | |
Secondary | Blood Pressure | Measured blood pressure (mmHG) - systolic and diastolic | Baseline to 24 months | |
Secondary | Weight | Measured weight (nearest kg) | Baseline to 12 months | |
Secondary | Weight | Measured weight (nearest kg) | Baseline to 24 months | |
Secondary | Social Support for Diet and Exercise Behaviors | self report measure of social support (family, friend) in performing diet and exercise behaviors | Baseline to 6 months | |
Secondary | Social Support for Diet and Exercise Behaviors | self report measure of social support (family, friend) in performing diet and exercise behaviors | Baseline to 12 months | |
Secondary | Social Support for Diet and Exercise Behaviors | self report measure of social support (family, friend) in performing diet and exercise behaviors | Baseline to 24 months | |
Secondary | Self Efficacy for Diet and Exercise Behaviors | self report measure of confidence in performing diet and exercise behaviors | Baseline to 6 months | |
Secondary | Self Efficacy for Diet and Exercise Behaviors | self report measure of confidence in performing diet and exercise behaviors | Baseline to 12 months | |
Secondary | Self Efficacy for Diet and Exercise Behaviors | self report measure of confidence in performing diet and exercise behaviors | Baseline to 24 months | |
Secondary | Automated Self-Administered 24-Hour Dietary Assessment Tool (ASA24) | self report measure of dietary intake | Baseline to 6 months | |
Secondary | Automated Self-Administered 24-Hour Dietary Assessment Tool (ASA24) | self report measure of dietary intake | Baseline to 12 months | |
Secondary | Automated Self-Administered 24-Hour Dietary Assessment Tool (ASA24) | self report measure of dietary intake | Baseline to 24 months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05346796 -
Survivorship Plan HEalth REcord (SPHERE) Implementation Trial
|
N/A | |
Recruiting |
NCT05094804 -
A Study of OR2805, a Monoclonal Antibody Targeting CD163, Alone and in Combination With Anticancer Agents
|
Phase 1/Phase 2 | |
Completed |
NCT04867850 -
Effect of Behavioral Nudges on Serious Illness Conversation Documentation
|
N/A | |
Enrolling by invitation |
NCT04086251 -
Remote Electronic Patient Monitoring in Oncology Patients
|
N/A | |
Completed |
NCT01285037 -
A Study of LY2801653 in Advanced Cancer
|
Phase 1 | |
Completed |
NCT00680992 -
Study of Denosumab in Subjects With Giant Cell Tumor of Bone
|
Phase 2 | |
Completed |
NCT00062842 -
Study of Irinotecan on a Weekly Schedule in Children
|
Phase 1 | |
Active, not recruiting |
NCT04548063 -
Consent Forms in Cancer Research: Examining the Effect of Length on Readability
|
N/A | |
Completed |
NCT04337203 -
Shared Healthcare Actions and Reflections Electronic Systems in Survivorship
|
N/A | |
Recruiting |
NCT04349293 -
Ex-vivo Evaluation of the Reactivity of the Immune Infiltrate of Cancers to Treatments With Monoclonal Antibodies Targeting the Immunomodulatory Pathways
|
N/A | |
Terminated |
NCT02866851 -
Feasibility Study of Monitoring by Web-application on Cytopenia Related to Chemotherapy
|
N/A | |
Active, not recruiting |
NCT05304988 -
Development and Validation of the EFT for Adolescents With Cancer
|
||
Completed |
NCT00340522 -
Childhood Cancer and Plexiform Neurofibroma Tissue Microarray for Molecular Target Screening and Clinical Drug Development
|
||
Recruiting |
NCT04843891 -
Evaluation of PET Probe [64]Cu-Macrin in Cardiovascular Disease, Cancer and Sarcoidosis.
|
Phase 1 | |
Active, not recruiting |
NCT03844048 -
An Extension Study of Venetoclax for Subjects Who Have Completed a Prior Venetoclax Clinical Trial
|
Phase 3 | |
Completed |
NCT03109041 -
Initial Feasibility Study to Treat Resectable Pancreatic Cancer With a Planar LDR Source
|
Phase 1 | |
Completed |
NCT03167372 -
Pilot Comparison of N-of-1 Trials of Light Therapy
|
N/A | |
Terminated |
NCT01441115 -
ECI301 and Radiation for Advanced or Metastatic Cancer
|
Phase 1 | |
Recruiting |
NCT06206785 -
Resting Energy Expenditure in Palliative Cancer Patients
|
||
Recruiting |
NCT05318196 -
Molecular Prediction of Development, Progression or Complications of Kidney, Immune or Transplantation-related Diseases
|